<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03889717</url>
  </required_header>
  <id_info>
    <org_study_id>DPTL</org_study_id>
    <nct_id>NCT03889717</nct_id>
  </id_info>
  <brief_title>Comparison of Two Different Doses of Vitamin D in Preterm Infants</brief_title>
  <official_title>A Randomized Controlled Trial Comparing Two Regimens of Vitamin D Supplementation in Preterm Neonates</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      randomized clinical trial comparing two different doses of vitamin d supplementation in
      preterm infants
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      after randomization each group of preterm neonates (28-32) weeks consisting of 40 neonates

      within 48 hrs of birth baseline ca.phosphorus, alkaline phosphatase and vitamin D level were
      withdrawn from each neonate

      then babies started to take oral vitamin d in different doses (400 IU /day in the 1st group
      and 1000 iu per day in the 2nd group) after they reach 100 cc per kg per day enteral feeding

      after they complete 40th week gestational age the investigators repeat the labs again ( serum
      ca, phosphorus,alp and vitamin D and compare the rate of rise in vitamin D and calcium
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 16, 2019</start_date>
  <completion_date type="Anticipated">June 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">June 15, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>after randomization ,two different groups of premature neonates are enrolled in the study baseline calcium,phosphorus and alp and vitamin D withdrawn at the 1st 48 hrs, then neonates started to administer vitamin D drops after they reached 100 cc per kg per day until they complete 40th week gestational age .follow up labs will be done at this age to determine which dose is better in vitamin d deficiency prevention</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Compare the level of serum 25 hydroxy vitamin D between the two groups of newborns. 2- Detect vitamin D deficiency among both groups.</measure>
    <time_frame>1 month</time_frame>
    <description>measurement of the level after supplementation</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Osteopenia of Prematurity</condition>
  <arm_group>
    <arm_group_label>400 iu</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>neonates who will receive vitamin d dose at 400 iu per day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1000 iu</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>neonates who will receive vitamin d dose 1000 iu per day</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>vitamin D</intervention_name>
    <description>vitamin d drops will be given daily to the 2 groups of neonates ( 1st group will be given 400 iu /day and 2nd group will be given 1000 iu per day ) when they reach 100 cc per kg enteral feeding .. until they reach 40 weeks gestational age</description>
    <arm_group_label>1000 iu</arm_group_label>
    <arm_group_label>400 iu</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Preterm infants delivered at a gestational age ≤ 32 weeks

          -  Birth weight ≤1500 kg

        Exclusion Criteria:

          -  Neonates with major congenital anomalies,

          -  maternal condition or medications likely to influence vitamin D or calcium metabolism

          -  neonates not receiving 100 ml/ kg / day of enteral feeds by 14 days of life
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Dina Basta, master</last_name>
    <phone>00201002866168</phone>
    <email>deena-gamal@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>douaa Ibrahim, master</last_name>
    <phone>00201006155597</phone>
    <email>douaa.galal@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kasr alainy</name>
      <address>
        <city>Cairo</city>
        <zip>002</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>March 22, 2019</study_first_submitted>
  <study_first_submitted_qc>March 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 26, 2019</study_first_posted>
  <last_update_submitted>April 25, 2019</last_update_submitted>
  <last_update_submitted_qc>April 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Dina Jamal Abd elmoez abd elmegeed Basta</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bone Diseases, Metabolic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

